Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 245-524-2 | CAS number: 23251-72-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
With its relatively low molecular weight (~165 g/mol) and high water solubility (≥1000 g/L), it is likely that DEA acetate will be absorbed from the gastro-intestinal tract. As such, oral absorption of DEA acetate is set at 100%.
Although not expected to reach the lungs (due to its low vapour pressure), as a very hydrophilic substance with a relatively low molecular weight, any DEA acetate reaching the lungs might be absorbed through aqueous pores. As such, the inhalation absorption is set at 100%.
DEA acetate, with water solubility above 1000 g/l and a log Pow value below 0, may be too hydrophilic to cross the lipid rich environment of the stratum corneum. As such, 10% dermal absorption is proposed.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 100
Additional information
In general, a compound needs to be dissolved before it can be taken up from the gastro-intestinal tract after oral administration. The relatively small molecular weight (~165 g/mol) and the high water solubility (≥1000 g/L) indicates that uptake of DEA acetate can take place through aqueous pores. It is therefore likely that this compound will be absorbed from the gastro-intestinal tract. As such, oral absorption of DEA acetate is set at 100%.
Once absorbed, distribution of DEA acetate throughout the body is expected based on its relatively low molecular weight, and no accumulation in the body is anticipated based on its hydrophilic character. DEA acetate has characteristics favourable for fast urinary excretion: low molecular weight (below 300 g/mol) and good water solubility. Based on its hydrophilic character, extracellular concentration is also expected to be higher than intracellular concentration. The rate at which this highly water-soluble molecule distributes may be limited by the rate at which it crosses cell membranes and access of this substance to the central nervous system (CNS) or testes is likely to be restricted by the blood-brain and blood-testes barriers.
Due to the low vapour pressure (1.68 Pa) and high water solubility (1000 g/L) of the substance, it is not to be expected that DEA acetate will reach the nasopharyncheal region or subsequently the tracheobronchial or pulmonary region. As a very hydrophilic substance with a relatively low molecular weight, any DEA acetate reaching the lungs might be absorbed through aqueous pores or be retained in the mucus and transported out of the respiratory tract. Overall, although it is very unlikely that DEA acetate will be available to a high extent after inhalation via the lungs due to the low vapour pressure and high water solubility, the inhalation absorption is set at a default of 100%.
Estimation of dermal absorption is based on relevant available information (mainly water solubility, molecular weight and log Kow) and expert judgement. DEA acetate, with water solubility above 1000 g/l and a log Pow expected to be below 0, may be too hydrophilic to cross the lipid rich environment of the stratum corneum. As such, 10% dermal absorption of DEA acetate is proposed.
DEA acetate is suspected of having a low potential for bioaccumulation based on its predicted physical-chemical properties (i.e. Log Pow < 0).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.